NCT01274156

Brief Summary

This study aims to evaluate the effect of shockwave therapy on erectile dysfunction on patients responding to PDE5i therapy in a sham controlled randomized double blind manner.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Aug 2010

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2010

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

December 14, 2010

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 11, 2011

Completed
Last Updated

January 11, 2011

Status Verified

January 1, 2011

Enrollment Period

3 months

First QC Date

December 14, 2010

Last Update Submit

January 10, 2011

Conditions

Keywords

Erectile dysfunctionLow Intensity Shock Wave

Outcome Measures

Primary Outcomes (1)

  • International Index of Erectile function- Erectile Function Domain

    An increase in score of 5points and above will be considered success.

    At screening and 17 weeks later at last visit

Secondary Outcomes (2)

  • Rigidity scale

    At screening and 17 weeks later at last visit

  • Flow Mediated Dilatation Technique

    At screening and 17 weeks later at last visit

Study Arms (2)

shock wave treatment

ACTIVE COMPARATOR
Device: "MEDISPEC" treatment probeDevice: "MEDISPEC" Low intensity shock waves

"MEDISPEC" Sham

SHAM COMPARATOR

"MEDISPEC" Probe does not deliver energy but creates same noise and sensation of active probe

Device: "MEDISPEC" Sham ProbeDevice: Sham

Interventions

300 shocks in 5 different anatomical locations of the penis.

Also known as: VASCUSPEC
shock wave treatment

Sham probe applied same as treatment probe without energy

Also known as: VASCUSPEC
"MEDISPEC" Sham

Treatment parameters will be as follows: Intensity: 0.09 mj/mm2 ,300 shocks per site, on 5 penile anatomical sites. Total number of shock waves: 1500/ session Frequency of 120/min

Also known as: VASCULOSPEC
shock wave treatment
ShamDEVICE

Probe does not deliver energy but creates same noise and sensation of active probe

Also known as: Vasculospec
"MEDISPEC" Sham

Eligibility Criteria

Age20 Years - 80 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ED of more than 6 months
  • Rigidity score ≥ 3 under PDE5i therapy
  • SHIM ≤21 under PDE5i therapy
  • Non- hormonal, neurological or psychological pathology
  • Stable heterosexual relationship for more than 3 months

You may not qualify if:

  • Prior prostatectomy surgery
  • Any unstable medical, psychiatric, spinal cord injury and penile anatomical abnormalities
  • Clinically significant chronic hematological disease
  • Anti-androgens, oral or injectable androgens
  • Radiotherapy in pelvic region

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rambam Health Care Campus

Haifa, Israel, 31096, Israel

Location

MeSH Terms

Conditions

Erectile Dysfunction

Condition Hierarchy (Ancestors)

Genital Diseases, MaleGenital DiseasesUrogenital DiseasesSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 14, 2010

First Posted

January 11, 2011

Study Start

August 1, 2010

Primary Completion

November 1, 2010

Study Completion

November 1, 2010

Last Updated

January 11, 2011

Record last verified: 2011-01

Locations